It delivers radiation 400 times faster than existing methods.

它输送辐射的速度比现有方法快400倍。

IHH Healthcare

IHH医疗保健

has invested in US-based medical technology company TibaRay to support the development and deployment of next-generation radiation therapy systems for cancer treatment.

已投资美国医疗技术公司TibaRay，以支持下一代用于癌症治疗的放射治疗系统的开发和部署。

The investment supports IHH’s transformation agenda and its Centres of Excellence strategy in oncology, cardiology and orthopaedics, as the Group looks to scale new technologies across its hospital network.

这项投资支持了IHH的转型议程及其在肿瘤学、心脏病学和骨科领域的卓越中心战略，因为该集团希望在其医院网络中推广新技术。

TibaRay is developing proprietary linear accelerators designed to deliver radiation at ultra-high speeds — more than 400 times faster than current systems — while maintaining high precision. The technology aims to shorten treatment times, improve dose control and reduce radiation exposure to healthy tissue..

TibaRay 正在开发专有的直线加速器，旨在以超高速度提供辐射——比现有系统快 400 倍以上——同时保持高精度。该技术旨在缩短治疗时间、改进剂量控制并减少对健康组织的辐射暴露。

The systems are based on research and patents from institutions including Stanford University, SLAC National Accelerator Laboratory, and Arizona State University.

这些系统基于来自斯坦福大学、SLAC国家加速器实验室和亚利桑那州立大学等机构的研究和专利。

TibaRay Chief Executive Officer Thinh Tran said the partnership comes as the company prepares to launch Galactica, its first commercial system.

TibaRay首席执行官Thinh Tran表示，此次合作正值公司准备推出其首个商业系统Galactica之际。

Under the collaboration, IHH and TibaRay will work on clinical evaluations, knowledge sharing and future deployment of the technology across IHH’s network in key markets.

根据合作协议，IHH和TibaRay将针对IHH在关键市场网络中的技术进行临床评估、知识共享及未来部署工作。